|
SPATA2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.558000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.579000E-03 |
| Normal-vs-Stage2 |
1.434040E-01 |
| Normal-vs-Stage3 |
1.428360E-01 |
| Normal-vs-Stage4 |
1.237240E-01 |
| Stage1-vs-Stage2 |
5.791200E-01 |
| Stage1-vs-Stage3 |
1.572800E-01 |
| Stage1-vs-Stage4 |
3.434600E-01 |
| Stage2-vs-Stage3 |
7.066200E-01 |
| Stage2-vs-Stage4 |
8.628000E-01 |
| Stage3-vs-Stage4 |
8.434000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.602000E-03 |
| Normal-vs-AfricanAmerican |
5.786500E-02 |
| Normal-vs-Asian |
1.080270E-02 |
| Caucasian-vs-AfricanAmerican |
9.906000E-01 |
| Caucasian-vs-Asian |
7.041600E-01 |
| AfricanAmerican-vs-Asian |
7.860600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.038000E-02 |
| Normal-vs-Female |
5.483900E-03 |
| Male-vs-Female |
2.411600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.837200E-04 |
| Normal-vs-Age(41-60Yrs) |
8.401800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.321400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.262450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.748260E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.142200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.646000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.346200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.745000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.264800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.675100E-03 |
| Classical-VS-Follicular |
9.362200E-04 |
| Classical-VS-Other |
7.861200E-01 |
| Classical-VS-Normal |
8.604100E-04 |
| Tall-VS-Follicular |
8.171800E-01 |
| Tall-VS-Other |
8.395900E-02 |
| Tall-VS-Normal |
8.242200E-01 |
| Follicular-VS-Other |
1.619410E-01 |
| Follicular-VS-Normal |
5.950600E-01 |
| Other-VS-Normal |
9.518300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.326200E-02 |
| Normal-vs-N1 |
4.062400E-02 |
| N0-vs-N1 |
1.991030E-01 |
|
|
